Danwei Huangfu

10.6k total citations · 5 hit papers
50 papers, 7.5k citations indexed

About

Danwei Huangfu is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, Danwei Huangfu has authored 50 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 15 papers in Surgery and 15 papers in Genetics. Recurrent topics in Danwei Huangfu's work include CRISPR and Genetic Engineering (24 papers), Pluripotent Stem Cells Research (22 papers) and Pancreatic function and diabetes (15 papers). Danwei Huangfu is often cited by papers focused on CRISPR and Genetic Engineering (24 papers), Pluripotent Stem Cells Research (22 papers) and Pancreatic function and diabetes (15 papers). Danwei Huangfu collaborates with scholars based in United States, Israel and Japan. Danwei Huangfu's co-authors include Kathryn V. Anderson, Douglas A. Melton, Wenjun Guo, René Maehr, Astrid Eijkelenboom, Andrew S. Rakeman, Zeng‐Rong Zhu, Aimin Liu, Lee Niswander and Noel Murcia and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Danwei Huangfu

46 papers receiving 7.4k citations

Hit Papers

Induction of pluripotent stem cells by defined factors is... 2003 2026 2010 2018 2008 2003 2008 2005 2009 400 800 1.2k

Peers

Danwei Huangfu
Styliani Markoulaki United States
Peter J. Donovan United States
Olivia Kelly United States
Guangming Wu Germany
Qi‐Long Ying United States
Matthias Stadtfeld United States
Danwei Huangfu
Citations per year, relative to Danwei Huangfu Danwei Huangfu (= 1×) peers Konstantinos Anastassiadis

Countries citing papers authored by Danwei Huangfu

Since Specialization
Citations

This map shows the geographic impact of Danwei Huangfu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danwei Huangfu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danwei Huangfu more than expected).

Fields of papers citing papers by Danwei Huangfu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danwei Huangfu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danwei Huangfu. The network helps show where Danwei Huangfu may publish in the future.

Co-authorship network of co-authors of Danwei Huangfu

This figure shows the co-authorship network connecting the top 25 collaborators of Danwei Huangfu. A scholar is included among the top collaborators of Danwei Huangfu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danwei Huangfu. Danwei Huangfu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yan, Jielin, Renhe Luo, Bess P. Rosen, et al.. (2025). Discovery of NANOG enhancers and their essential roles in self-renewal and differentiation in human embryonic stem cells. Stem Cell Reports. 20(6). 102511–102511.
3.
Rosen, Bess P., Qing V. Li, Hyunwoo Cho, et al.. (2024). Parallel genome-scale CRISPR-Cas9 screens uncouple human pluripotent stem cell identity versus fitness. Nature Communications. 15(1). 8966–8966. 4 indexed citations
4.
Chen, Tingxu, Heather Alcorn, Sujan Devbhandari, et al.. (2022). A hypomorphic mutation in Pold1 disrupts the coordination of embryo size expansion and morphogenesis during gastrulation. Biology Open. 11(8). 1 indexed citations
5.
Kahraman, Sevim, Ercument Dirice, Giorgio Basile, et al.. (2022). Abnormal exocrine–endocrine cell cross-talk promotes β-cell dysfunction and loss in MODY8. Nature Metabolism. 4(1). 76–89. 33 indexed citations
6.
Vanoli, Fabio, Laurie Herviou, Yun‐Shao Sung, et al.. (2021). Generation of human embryonic stem cell models to exploit the EWSR1-CREB fusion promiscuity as a common pathway of transformation in human tumors. Oncogene. 40(32). 5095–5104. 11 indexed citations
7.
Li, Qing V., Bess P. Rosen, & Danwei Huangfu. (2019). Decoding pluripotency: Genetic screens to interrogate the acquisition, maintenance, and exit of pluripotency. WIREs Systems Biology and Medicine. 12(1). e1464–e1464. 7 indexed citations
8.
Vardhana, Santosha A., Paige K. Arnold, Bess P. Rosen, et al.. (2019). Glutamine independence is a selectable feature of pluripotent stem cells. Nature Metabolism. 1(7). 676–687. 45 indexed citations
9.
Amin, Sadaf, Brandoch D. Cook, Ting Zhou, et al.. (2018). Discovery of a drug candidate for GLIS3-associated diabetes. Nature Communications. 9(1). 2681–2681. 47 indexed citations
10.
Shukla, Abhijit & Danwei Huangfu. (2018). Decoding the noncoding genome via large-scale CRISPR screens. Current Opinion in Genetics & Development. 52. 70–76. 21 indexed citations
11.
Shi, Zhong‐Dong, Chew-Li Soh, Zeng‐Rong Zhu, & Danwei Huangfu. (2017). Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development. Journal of Visualized Experiments. 3 indexed citations
12.
Shi, Zhong‐Dong, Chew-Li Soh, Zeng‐Rong Zhu, & Danwei Huangfu. (2017). Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development. Journal of Visualized Experiments. 1 indexed citations
13.
Zhu, Zeng‐Rong, Qing V. Li, Kihyun Lee, et al.. (2016). Genome Editing of Lineage Determinants in Human Pluripotent Stem Cells Reveals Mechanisms of Pancreatic Development and Diabetes. Cell stem cell. 18(6). 755–768. 132 indexed citations
14.
Soh, Chew-Li & Danwei Huangfu. (2016). CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium. Methods in molecular biology. 1498. 57–78. 7 indexed citations
15.
Verma, Nipun, Zeng‐Rong Zhu, & Danwei Huangfu. (2016). CRISPR/Cas-Mediated Knockin in Human Pluripotent Stem Cells. Methods in molecular biology. 1513. 119–140. 12 indexed citations
16.
Kotini, Andriana G., Ibrahim Boussaad, Jeffrey J. Delrow, et al.. (2015). Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nature Biotechnology. 33(6). 646–655. 120 indexed citations
17.
Benitah, Salvador Aznar, Adrian P. Bracken, Yali Dou, et al.. (2014). Stem Cell Epigenetics: Looking Forward. Cell stem cell. 14(6). 706–709.
18.
Zhu, Zeng‐Rong, Federico Gonzãlez, & Danwei Huangfu. (2014). The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells. Methods in enzymology on CD-ROM/Methods in enzymology. 546. 215–250. 49 indexed citations
19.
Gonzãlez, Federico, Zeng‐Rong Zhu, Zhong‐Dong Shi, et al.. (2014). An iCRISPR Platform for Rapid, Multiplexable, and Inducible Genome Editing in Human Pluripotent Stem Cells. Cell stem cell. 15(2). 215–226. 352 indexed citations
20.
Ichida, Justin K., Joel Blanchard, Kelvin Lam, et al.. (2009). A Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog. Cell stem cell. 5(5). 491–503. 612 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026